Carlyle Group Inc.Carlyle Group Inc.

Institutional investor · Portfolio as of Q3 2022

Top Holdings11 positions

Checking export access…
Activity:

ZOOMINFO TECHNOLOGIES INC-A

38M$1.6B50.3%$50.72-17.88%
10 qtrssince 2020-Q2
Decreased
0

QUIDELORTHO CORP

12.5M$890.7M28.3%$100.03-28.04%
2 qtrssince 2022-Q2
Unchanged
0

MKS INSTRS INC

3.4M$280.4M8.9%$82.670.00%
1 qtr
New
98
ONEMONEMDelisted

1LIFE HEALTHCARE INC

13.6M$233.5M7.4%——
11 qtrssince 2020-Q1
Unchanged
0
VTRUVTRUDelisted

VITRU LTD

6.2M$131M4.2%——
9 qtrssince 2020-Q3
Unchanged
0
LSILSIDelisted
REIT

LIFE STORAGE INC

86,000$9.5M0.3%——
1 qtr
New
49
CUBECUBE
REIT

CUBESMART

220,500$8.8M0.3%$32.920.00%
1 qtr
New
49

SEACOR MARINE HLDGS INC

1.2M$6.7M0.2%$11.06-52.46%
16 qtrssince 2018-Q4
Unchanged
0
EMEMDelisted
ADR

SMART SH GLOBAL LTD

4.8M$3.4M0.1%$1.12-38.39%
2 qtrssince 2022-Q2
Unchanged
0

SIRIUSPOINT LTD

129,408$641,0000.0%$10.29-52.38%
7 qtrssince 2021-Q1
Unchanged
0
314,400$324,0000.0%——
2 qtrssince 2022-Q2
Unchanged
0
$3.1B
AUM
11
Positions
Q3 2022
Filing
HI score · 1.0/5
Quarterly 13F Value Change
-17%Q3'20$7.3B+2%Q4'20$7.5B+77%Q1'21$13.2B-76%Q3'22$3.1B
Activity profile
$ moved · Q3'22
New9%Increased0%Decreased6%Exited86%
Composition
Equity vs derivatives
Equity100%Puts0%Calls0%
Holding period
Avg 1.2 years
<1Q27%1-4Q27%1-2Y9%2Y+36%

Carlyle Group Inc. manages $3.1B across 11 positions as of Q3 2022. Top holdings: GTM (50.3%), QDEL (28.3%), MKSI (8.9%). Fund DNA: Balanced Allocator. HoldingsIntel Score: 1/5.0.

Q3 2022 Summary

Added 3 new positions, exited 1, trimmed 1. Top move: MKSI (NEW, conviction 98). Portfolio: $3.1B across 11 positions.

Top holdings by portfolio weight

Total AUM$3B
GTM50.30%
QDEL28.28%
MKSI8.90%
ONEM7.41%
VTRU4.16%
LSI0.30%
CUBE0.28%
SMHI0.21%
EM0.11%
SPNT0.02%
Other0.01%

Portfolio allocation by GICS sector

Sectors7
Technology59.21%
Healthcare28.28%
Unknown11.89%
Real Estate0.28%
Industrials0.21%
Consumer Cyclical0.11%
Financial Services0.02%

Behavioral investing profile

Checking access…
Balanced Allocator- primarily Technology, Healthcare, Unknown
Compare DNA across all funds
7-dimension, SEC 13F-derived research score
Weak(1.0 / 5.0)
Holdings P&L12
Conviction38
Concentration100
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Top Losers

Checking access…

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

No active accumulation streaks detected for this filer.

Streaks require 2+ consecutive quarters of increased positions in the most recent period.

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Verify source filings on SEC EDGAR

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used